Kathryn E. Falberg - Insider Trading & Ownership

Entity
Individual
Location
C/O Axovant Sciences, Inc., 320 West 37 Th Street, 5 Th Floor, New York, New York
Summary
The estimated net worth of Kathryn E. Falberg is at least $29 M dollars as of June 7, 2024. Kathryn E. Falberg is the Director of Trade Desk, Inc. and owns shares of Trade Desk, Inc. (TTD) stock worth about $25.9 M. Kathryn E. Falberg is the Director of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $2.76 M. Kathryn E. Falberg is the Director of Nuvation Bio Inc. and owns shares of Nuvation Bio Inc. (NUVB) stock worth about $340 K.
All Insider Reports
All Insider Reports

Ownership of Kathryn E. Falberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TTD Trade Desk, Inc. Director $25.9 M -$8.44 M -24.6% May 28, 2024
RCUS Arcus Biosciences, Inc. Director $2.76 M Jun 6, 2024
NUVB, NUVB-WT Nuvation Bio Inc. Director $340 K May 15, 2023
TCDA Tricida, Inc. Director Jun 15, 2022
URGN UroGen Pharma Ltd. Director Jun 7, 2021

Insider Transactions Reported by Kathryn E. Falberg:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership